Skip to Content

Imiquimod

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D06BB10

CAS registry number (Chemical Abstracts Service)

0099011-02-6

Chemical Formula

C14-H16-N4

Molecular Weight

240

Therapeutic Categories

Antivirals for systemic use - Antiviral agent

Immunomodulator

Chemical Name

1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-metylpropyl)-

Foreign Names

  • Imiquimodum (Latin)
  • Imiquimod (German)
  • Imiquimod (French)
  • Imiquimod (Spanish)

Generic Names

  • Imiquimod (OS: USAN, BAN, DCF, JAN)
  • R 837 (IS)
  • S 26308 (IS)
  • Zartra (IS)
  • Imiquimod (PH: USP 41)

Brand Names

  • Aldara
    3M, China; 3M, Georgia; 3M, Kenya; 3M, Kuwait; 3M Health Care, Lebanon; Bausch & Lomb, New Zealand; Dong-A, South Korea; iNova, Hong Kong; iNova, Malaysia; iNova, Philippines; iNova, South Africa; iNova Pharmaceuticals, Australia; Laboratorios Euromed Chile, Chile; Meda, Bosnia & Herzegowina; Meda, Belgium; Meda, Denmark; Meda, Estonia; Meda, Ireland; Meda, Italy; Meda, Lithuania; Meda, Latvia; Meda, Norway; Meda, Poland; Meda, Portugal; Meda, Sweden; Meda GmbH Beograd, Serbia; Meda Pharma, Czech Republic; Meda Pharma, Slovakia; Meda Pharma Sau, Spain; Medical Intertrade, Croatia (Hrvatska); Medicis Dermatologics, United States; More Pharma Corporation, Costa Rica; More Pharma Corporation, Guatemala; More Pharma Corporation, Honduras; More Pharma Corporation, Panama; More Pharma Corporation, El Salvador; Valeant Canada, Canada; Meda AB, Greece; Meda Pharmaceuticals, Russian Federation; More Pharma, Mexico; GlaxoSmithKline China Investment, China; iNova Pharma Thailand Co., Thailand
  • Aldara 5%
    3 M Health Care, Oman; 3M Health Care, Israel; Emra-Med Arzneimittel, Austria; Eurim-Pharm, Austria; Haemato Pharm, Austria; Meda, Austria; Meda, France; Meda, Hungary; Meda, Iceland; Meda, Luxembourg; Meda, Romania; Meda, Turkey; Meda AB, Slovenia; MEDA Pharma, Switzerland; MEDA Pharma, Germany; Meda Pharmaceuticals, Cyprus; Meda Pharmaceuticals, United Kingdom; Mediwin, France
  • Aldiq
    Aspen Pharmacare, Australia
  • Apo-Imiquimod
    Apotex, Australia; Apotex, New Zealand
  • Aquimod 5%
    Taro, Israel
  • Bascellex
    Sun Pharma, Netherlands; Sun Pharmaceuticals UK, United Kingdom
  • Beselna 5%
    Mochida Pharmaceutical, Japan
  • Imicare
    Medinfar, Portugal
  • Imik
    Abbott, Colombia; Servimedic, Uruguay
  • Imimore 2.5%
    Panalab, Argentina
  • Imimore 3.75%
    Panalab, Argentina
  • Imimore 5%
    Panalab, Argentina; Panalab, Peru
  • Imiquad
    Glenmark, India; Glenmark Pharmaceuticals, Vietnam
  • Imiquimod
    Apotex, United States; Fougera, United States; Glenmark Generics, United States; Landsteiner, Mexico; Orion, New Zealand; Perrigo, United States; Strides Pharma, United States; Taro Pharmaceuticals USA, United States; Tolmar, United States
  • Imiquimod Dutriec
    Dutriec, Paraguay
  • Imiquimod Lafedar
    Lafedar, Argentina
  • Imiquimod Novophar
    Novophar, Paraguay
  • Imunocare
    Cantabria, Spain
  • Labimiq 5%
    ITF - Labomed Farmaceutica, Chile
  • Li Di
    Mingxin Pharmaceutical, China
  • Li Ke Jie
    Keyi Pharmaceutical, China
  • Miquimod
    Lazar, Argentina; Lazar, Ecuador; Lazar, Uruguay
  • Miquimod 3.75
    Lazar, Argentina
  • Modik
    Germed Farmaceutica, Brazil
  • Modiwart
    Pharmazac SA, Greece
  • Modulcass
    Cassara, Argentina; MediHealth, Uruguay
  • Nan Bo
    Topfond Pharmaceutical Co.,Ltd, China
  • Nilwart
    Dr. Reddy's, India
  • Peltz
    Grisi Hnos, Mexico
  • Perrimod
    Perrigo, Israel
  • Quimara-1
    Liomont, Mexico
  • Quimodia
    Epsilon, Greece
  • Quinilan
    Raymos, Argentina
  • Tian Rui
    Yangtze River Pharma, China
  • Virosupril
    MediHealth, Uruguay; Raymos, Argentina
  • Virosupril 3.75%
    Raymos, Argentina
  • Vyloma
    Valeant Canada, Canada
  • You Care
    Nang Kuang, Taiwan
  • Youbiqing
    The United Laboratories, China
  • Zyclara
    Graceway, United States; Meda, Denmark; Meda, Estonia; Meda, Lithuania; Meda, Latvia; Meda, Norway; Meda, Poland; Meda, Sweden; Meda AB, Slovenia; Meda Pharma, Netherlands; Medicis Dermatologics, United States; Valeant Canada, Canada
  • Zyclara 3,75%
    Eurim-Pharm, Austria; Meda, Austria; Meda, Ireland; MEDA Pharma, Germany
  • Zyclara 3.75%
    Meda Pharma Sau, Spain; Meda Pharmaceuticals, United Kingdom
  • Zyclara 37.5mg/g
    MEDA Pharma, Switzerland

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide